(NASDAQ: RZLT) Rezolute's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 47.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.59%.
Rezolute's earnings in 2025 is -$77,184,000.On average, 12 Wall Street analysts forecast RZLT's earnings for 2026 to be -$105,199,385, with the lowest RZLT earnings forecast at -$149,940,419, and the highest RZLT earnings forecast at -$82,759,322. On average, 9 Wall Street analysts forecast RZLT's earnings for 2027 to be -$83,770,052, with the lowest RZLT earnings forecast at -$109,956,307, and the highest RZLT earnings forecast at -$40,892,842.
In 2028, RZLT is forecast to generate -$22,134,062 in earnings, with the lowest earnings forecast at -$61,793,627 and the highest earnings forecast at $42,840,120.